4-butyrolactone has been researched along with Cancer of Kidney in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, T; Hosaka, Y; Kasuya, Y; Kitamura, T; Matsushima, H; Okuyama, A | 1 |
| Liu, G; Wang, W; Zheng, J | 1 |
| Gu, Z; Hopp, DC; McLaughlin, JL; Zeng, L | 1 |
| Cadman, TB; Degregorio, MW; Hammock, BD; Jones, AD; Wurz, GT; Zheng, J | 1 |
| Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Yamada, Y; Yonekura, K | 1 |
6 other study(ies) available for 4-butyrolactone and Cancer of Kidney
| Article | Year |
|---|---|
Prominent induction of cyclin B1 in G2/M renal cancer cells with butyrolactone 1.
Topics: 4-Butyrolactone; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; Cyclins; DNA, Neoplasm; Enzyme Inhibitors; Humans; Kidney Neoplasms | 2003 |
Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Topics: 4-Butyrolactone; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Chlorambucil; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Glutathione S-Transferase pi; Humans; Isoenzymes; Kidney Neoplasms; Melphalan; Transfection | 2007 |
Squamotacin: an annonaceous acetogenin with cytotoxic selectivity for the human prostate tumor cell line (PC-3).
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Artemia; Breast Neoplasms; Colonic Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Pancreatic Neoplasms; Plants, Medicinal; Prostatic Neoplasms; Tumor Cells, Cultured | 1996 |
Haloenol lactone: a new synergist of chemotherapy in vitro.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Survival; Cisplatin; Drug Synergism; Enzyme Inhibitors; Glutathione Transferase; Humans; Isoenzymes; Kidney Neoplasms; Kinetics; Tumor Cells, Cultured | 1997 |
UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Division; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Floxuridine; Fluorouracil; Hydroxybutyrates; Kidney Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Tegafur; Tumor Cells, Cultured; Uracil | 1999 |
[Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Sodium Oxybate; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 2000 |